在COVID-19后的肺部康复治疗
Jafar Aljazeeri1, Rayyan Almusally, Yijin Wert
1University of Pittsburgh Medical Center, Central Pennsylvania the United States (Drs Aljazeeri, Ramesh, and Rahman and Mss Wert and Klinger); Drexel University College of Medicine, Philadelphia, Pennsylvania, the United States (Drs Aljazeeri, Abdelhalim, and Ramesh); and Imam Abdulrahman Bin Faisal University, College of Medicine, Dammam, Saudi Arabia (Dr Almusally).
在COVID-19后的患者中,肺部康复显著改善了运动能力,并减少了呼吸障碍和抑郁症等症状. 建议采用这种方法来管理COVID-19感染后的长期呼吸道问题.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 康复科学 康复科学 康复科学
背景情况:
- 持续的呼吸道症状和运动不耐受是COVID-19后的常见后果.
- 关于长期COVID-19后呼吸道并发症的有效干预措施的证据有限.
研究的目的:
- 调查肺部康复 (PR) 在改善COVID-19后症状患者的治疗结果方面的有效性.
- 评估PR对该患者群体的运动能力,呼吸障碍和心理健康的影响.
主要方法:
- 一项观察性研究涉及56名连续接受8至12周门诊肺部康复计划的患者.
- 主要结局:改变6分钟步行测试 (6MWT) 距离. 二次结果:呼吸短促问卷 (SOBQ),修改的博格呼吸障碍量表,PHQ-9和LINQ.
主要成果:
- 肺部康复导致6MWT距离在平均84.3米 (P < .0001) 的显著改善.
- 在SOBQ (-16.9分),PHQ-9 (-2.6分) 和LINQ (-4.2分) 中观察到显著改善,表明呼吸不良,抑郁症状减少,肺部疾病知识改善 (P < .05).
结论:
- 肺部康复疗法在COVID-19后的患者身上显示出有前途的积极效果.
- PR有效地提高了运动能力,缓解了呼吸障碍的感知,减少了抑郁症状,并提高了自我管理知识.
- 肺部康复应该被强烈考虑为个人后COVID-19条件的治疗选择.
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chest Physiotherapy
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...


